Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
2.5 Fte (10)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Institut Gustave Roussy (IGR)
EU Transparency Register
498530042784-34 First registered on 03 Jun 2021
Goals / Remit
Recherche contre le cancer
Soins des personnes malades du cancer
EnseignementMain EU files targeted
Programmes européens d’intérêt (plans et financement) :
- European Beating Cancer Plan
- Mission on Cancer
- Cluster Health
- European Innovation Council (EIC)
- Marie Sklowdowska Curie (MSCA)
- Europe Research Council (ERC)
- Innovative Health Iniatives (IHI)
- EU4Health
- 2020/2267(INI): Strengthening Europe in the fight against cancer - towards a comprehensive and coordinated strategy
- 4.20.01 Medicine, diseases
- 4.20.05 Health legislation and policy
Principales législations et directives d’intérêt :
- Public Health Code
- Code of Medical Ethics
- Good Clinical Practices, Decision of November 24, 2006
- The Data Protection Act No. 78-17 of 6 January 1978, amended by Law 2018-493 of 20 June 2018 on the protection of individuals with regard to the processing of personal data, and by the decree Application No 2018-687 of 1 August 2018,
- The General Regulations on Data Protection (GDPR) of the European Union applicable since May 25, 2018.
- Regulation (EU) No 536/20141 on clinical trials on medicinal products for human use
- Directive 2002/98/EC of the European Parliament and of the Council of Europe dated 27th January 2003 and setting out standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components,
- Directive 2004/23/EC setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells and the further implementing Directives 2006/17/EC and 2006/86/EC concerning obligations regarding traceability, import/export of tissues and cells, notification of serious adverse events and reactions, donor selection and evaluation and safety of the samples (tissue and cell reception, processing and storage), labelling, documentation and packaging, distribution.Address
Head Office
39 rue Camille Desmoulins
Villejuif 94805
FRANCEEU Office
39 rue Camille Desmoulins
Villejuif 94805
FRANCEWebsite
-
People
Total lobbyists declared
10
Employment time Lobbyists 25% 10 Lobbyists (Full time equivalent)
2.5
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
Seuls nos plus importants chercheurs et médecins sont amenés à porter des projets européens et à interagir avec l'UE, soit dans le cadre de participation à des association européennes dont l'Institut Gustave Roussy est membre (CCE, WIN, OECI), soit dans le cadre d'associations professionnelles dont ils sont membres à titre individuel (ESTRO, SIOP etc.)
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Think tanks and research institutions
-
Networking
Affiliation
- Cancer Core Europe
- ITCC
- ESMO
- ESTRO
- SIOPE
- WIN
- OECIMember organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
480,178,178€
Major funding types in closed year
EU funding, Public financing, Grants
Major contributions in closed year
Type Name Amount Contribution Source national 5,336,764€ Contribution TP1 323,278,851€ Contribution Retrocession Medicament Assu. Maladie 9,495,589€ Contribution Dons 6,995,864€ Contribution Subvention UE 6,109,531€ Contribution Autre 128,961,580€ Grant Subvention UE 6,109,531€ Major contributions in current year
Type Name Amount Grant Subvention UE 139,492€ Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
Cancer
Communication activities
Publications scientifiques
Réponses à des appels d'offres scientifique européens
Plusieurs de nos médecins et chercheurs interviennent sur les questions de santé et sciences auprès des instances européennes via des association professionnelles auxquelles ils appartiennent
Membre de l'OECI, organisation des instituts européen du cancerOther activities
N/A
- Meetings
Meetings
None declared
- Meetings